Status:
COMPLETED
A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
Brief Summary
This observational study will explore the Swedish national population of patients with rheumatoid arthritis (RA) on infliximab maintenance therapy in order to identify patients who may be eligible for...
Detailed Description
Already known Subjects (RA and on at least 12 months ongoing Remicade treatment) from the clinic could participate if they are eligible.
Eligibility Criteria
Inclusion
- Rheumatoid arthritis, infliximab maintenance treatment for at least the past 12 months, given written informed consent.
Exclusion
- episodic treatment with infliximab
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
363 Patients enrolled
Trial Details
Trial ID
NCT00741104
Start Date
January 1 2008
End Date
June 1 2008
Last Update
January 4 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.